Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Proteasomal degradation of p53 is mediated by two alternative pathways that are either dependent or independent of both Mdm2 and ubiquitin. The ubiquitin-independent pathway is regulated by NAD(P)H: quinone oxidoreductase 1 (NQO1) that stabilizes p53. The NQO1 inhibitor dicoumarol induces ubiquitin-independent p53 degradation. We now show that, like dicoumarol, several other coumarin and flavone inhibitors of NQO1 activity, which compete with NAD(P)H for binding to NQO1, induced ubiquitin-independent p53 degradation and inhibited wild-type p53-mediated apoptosis. Although wild-type p53 and several p53 mutants were sensitive to dicoumarol-induced degradation, the most frequent “hot-spot” p53 mutants in human cancer, R175H, R248H, and R273H, were resistant to dicoumarol-induced degradation, but remained sensitive to Mdm2-ubiquitin-mediated degradation. The two alternative pathways for p53 degradation thus have different p53 structural requirements. Further mutational analysis showed that arginines at positions 175 and 248 were essential for dicoumarol-induced p53 degradation. NQO1 bound to wild-type p53 and dicoumarol, which induced a conformational change in NQO1, inhibited this binding. Compared with wild-type p53, the hot-spot p53 mutants showed increased binding to NQO1, which can explain their resistance to dicoumarol-induced degradation. NQO1 thus has an important role in stabilizing hot-spot p53 mutant proteins in human cancer.

Bibliography

Asher, G., Lotem, J., Tsvetkov, P., Reiss, V., Sachs, L., & Shaul, Y. (2003). p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proceedings of the National Academy of Sciences, 100(25), 15065–15070.

Authors 6
  1. Gad Asher (first)
  2. Joseph Lotem (additional)
  3. Peter Tsvetkov (additional)
  4. Veronica Reiss (additional)
  5. Leo Sachs (additional)
  6. Yosef Shaul (additional)
References 38 Referenced 54
  1. 10.1038/35042675
  2. 10.1038/387296a0
  3. 10.1038/387299a0
  4. 10.1073/pnas.202480499
  5. 10.1073/pnas.98.3.1188
  6. 10.1073/pnas.052706799
  7. Asher G. Lotem J. Sachs L. & Shaul Y. Methods Enzymol. in press.
  8. 10.1016/S0021-9258(19)42173-X
  9. 10.1074/jbc.M211981200
  10. Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. & Harris, C. C. (1994) Nucleic Acids Res. 22, 3551-3555.7937055 / Nucleic Acids Res. (1994)
  11. 10.1016/0092-8674(94)90519-3
  12. 10.1126/science.282.5393.1497
  13. 10.1093/carcin/14.5.987
  14. 10.1038/352345a0
  15. 10.1128/mcb.14.3.1997-2003.1994
  16. 10.1016/0092-8674(90)90113-S
  17. 10.1038/sj.onc.1205319
  18. 10.1101/gad.8.15.1739
  19. 10.1016/0006-2952(71)90294-2
  20. 10.1006/abbi.1993.1182
  21. 10.1124/mol.56.2.272
  22. 10.1021/bi00118a027
  23. Soussi, T. (2000) Ann. N.Y. Acad. Sci. 910, 121-139.10911910 (10.1111/j.1749-6632.2000.tb06705.x) / Ann. N.Y. Acad. Sci. (2000)
  24. 10.1038/sj.onc.1201459
  25. 10.1074/jbc.C000781200
  26. 10.1128/MCB.18.10.5690
  27. 10.1074/jbc.M102817200
  28. Malkinson, A. M., Siegel, D., Forrest, G. L., Gazdar, A. F., Oie, H. K., Chan, D. C., Bunn, P. A., Mabry, M., Dykes, D. J., Harrison, S. D., et al. (1992) Cancer Res. 52, 4752-4757.1324793 / Cancer Res. (1992)
  29. 10.1007/BF00689804
  30. Traver, R. D., Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H., Danenberg, P. V., Ross, D. & Gibson, N. W. (1992) Cancer Res. 52, 797-802.1737339 / Cancer Res. (1992)
  31. 10.1016/S0891-5849(00)00308-7
  32. 10.1021/bi011324i
  33. 10.1126/science.1069300
  34. 10.1073/pnas.1633591100
  35. 10.1016/S0092-8674(03)00552-X
  36. 10.1016/S0021-9258(17)36828-X
  37. 10.1016/S0092-8674(01)00524-4
  38. 10.1016/S0092-8674(01)00527-X
Dates
Type When
Created 21 years, 8 months ago (Dec. 9, 2003, 1:17 p.m.)
Deposited 1 year, 7 months ago (Jan. 11, 2024, 11:45 a.m.)
Indexed 3 months ago (May 19, 2025, 10:05 a.m.)
Issued 21 years, 9 months ago (Nov. 21, 2003)
Published 21 years, 9 months ago (Nov. 21, 2003)
Published Online 21 years, 9 months ago (Nov. 21, 2003)
Published Print 21 years, 8 months ago (Dec. 9, 2003)
Funders 0

None

@article{Asher_2003, title={p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1}, volume={100}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.2436329100}, DOI={10.1073/pnas.2436329100}, number={25}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Asher, Gad and Lotem, Joseph and Tsvetkov, Peter and Reiss, Veronica and Sachs, Leo and Shaul, Yosef}, year={2003}, month=nov, pages={15065–15070} }